PROSPECTS FOR MS DRUG OUTWEIGH DIP IN PROFIT AS SCHERING SHARES SOAR

PROSPECTS FOR MS DRUG OUTWEIGH DIP IN PROFIT AS SCHERING SHARES SOAR

Investors are unruffled by an unexpected quarterly profit decline at the Berlin-based chemicals grou